Burning Rock Biotech (BNR) Gains from Investment Securities (2019 - 2020)

Burning Rock Biotech (BNR) recorded quarterly Gains from Investment Securities of -$1.1 million in Q4 2020, down 310.62% quarter-over-quarter from $501937.0 in Q1 2020, and down 546.23% on a YoY basis from $236908.8 in Q1 2020.

Burning Rock Biotech (BNR) Gains from Investment Securities (2019 - 2020) Analysis & Trends

Burning Rock Biotech's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$1.1 million for Q4 2020.

  • In Q4 2020, Gains from Investment Securities fell 546.23% year-over-year to -$1.1 million; the TTM figure through Dec 2020 stood at -$555221.5 (down 37.03% YoY), while the FY2025 annual figure was $29000.0, down 14.71% from the prior year.
  • Gains from Investment Securities was -$1.1 million for Q4 2020 at Burning Rock Biotech, down from $501937.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $501937.0 in Q1 2020 to a low of -$1.1 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,010.71 Bn 30,010.25 Bn 1.11 Bn
2 Thermo Fisher Scientific 179.46 Bn 176.21 Bn 7.74 Bn
3 Danaher 130.33 Bn 124.64 Bn 3.59 Bn
4 Idexx Laboratories 44.44 Bn 44.24 Bn 722.74 Mn
5 Agilent Technologies 37.27 Bn 35.46 Bn 990.00 Mn
6 Iqvia Holdings 30.70 Bn 28.73 Bn 1.36 Bn
7 Natera 30.59 Bn 29.49 Bn 696.04 Mn
8 Illumina 24.86 Bn 23.71 Bn 721.00 Mn
9 Mettler Toledo International 23.06 Bn 23.00 Bn 555.82 Mn
10 Burning Rock Biotech 20.35 Mn -47.48 Mn 14.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 -1.06 Mn
Dec 31, 2020 -1.06 Mn
Mar 31, 2020 501,936.97
Mar 31, 2020 501,936.97
Dec 31, 2019 -163,588.53
Dec 31, 2019 -163,588.53
Sep 30, 2019 -200,164.08
Sep 30, 2019 -200,164.08
Jun 30, 2019 -50,910.35
Jun 30, 2019 -50,910.35
Mar 31, 2019 9,477.51
Mar 31, 2019 9,477.51